Related Experiment Video

Updated: Aug 29, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Effect of postmenopausal hormone replacement therapy on cardiovascular performance

Kurtulus Ozdemir1, Cetin Celik, Bülent B Altunkeser

  • 1Cardiology Department, Medical Faculty, Selçuk University, Aybüke Sitesi 83/14, 42080 Selçuklu, Konya, Turkey. kurt33@hotmail.com

Maturitas
|February 6, 2004
PubMed

Insights

Postmenopausal hormone replacement therapy (HRT) significantly improves cardiac function and exercise performance over six months. This therapy offers progressive benefits for left ventricular function in postmenopausal women.

Area of Science:

  • Cardiology
  • Endocrinology
  • Women's Health

Background:

  • Hormone replacement therapy (HRT) is typically studied for its effects on atherosclerotic disease.
  • Direct impacts of HRT on cardiac function in postmenopausal women remain less understood.

Purpose of the Study:

  • To investigate the long-term effects of HRT on cardiac function.
  • To assess the impact of HRT on exercise performance in postmenopausal women.

Main Methods:

  • Prospective analysis of 36 postmenopausal women using Doppler echocardiography and exercise stress tests.
  • Measurements included left ventricular ejection fraction (EF), filling velocities (E/A waves), deceleration time (EDT), myocardial performance index (MPI), exercise duration, and METS.
  • Data collected before HRT and at 3 and 6 months of treatment.

Main Results:

  • HRT did not significantly alter left ventricular ejection fraction (EF).
  • Significant improvements in E wave, EDT, E/A ratio, and MPI were observed by the sixth month of HRT.
  • Exercise duration and METS showed significant improvements by the third month, continuing to the sixth month.

Conclusions:

  • Postmenopausal HRT leads to progressive improvements in left ventricular function.
  • HRT also results in parallel improvements in exercise performance in postmenopausal women.
Abstract

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...